ImmunityBio (IBRX) Other Non-Current Assets (2014 - 2026)
ImmunityBio (IBRX) recorded Other Non-Current Assets of $15.4 million in Q2 2026, up 286.2% from $3.99 million a year earlier but down 2.2% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Other Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio reported Other Non-Current Assets of $4.91 million, up 1.7% from FY2024.
- Annual Other Non-Current Assets has a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $4.83 million in FY2024 (+67.6%), $2.88 million in FY2023 (-40.7%), $4.86 million in FY2022 (-28.3%) and $6.78 million in FY2021 (+160.8%).
- Quarterly Other Non-Current Assets has ranged from $2.66 million in Q2 2024 to $15.75 million in Q1 2026 over the past five years.
- On a year-over-year basis, Other Non-Current Assets has increased for eight consecutive quarters, with growth averaging 91.9% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 286.2% in Q2 2026, against a decline of 40.7% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $15.75 million (Q1 2026), $4.91 million (Q4 2025) and $4.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | ImmunityBio | 9.30 Bn | 8.06 Bn | 50.94 Mn | 15.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.40 Mn |
| Mar 31, 2026 | 15.75 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 4.47 Mn |
| Jun 30, 2025 | 3.99 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 2.88 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 3.77 Mn |
| Mar 31, 2023 | 4.55 Mn |
| Dec 31, 2022 | 4.86 Mn |
| Sep 30, 2022 | 5.13 Mn |
| Jun 30, 2022 | 6.02 Mn |
| Mar 31, 2022 | 6.48 Mn |
| Dec 31, 2021 | 6.78 Mn |
| Sep 30, 2021 | 7.44 Mn |
API Access
ImmunityBio Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();